Interaction of serotonin reuptake inhibitor and 3,4-methylenedioxymethamphetamine?
Lauerma
H
H
Wuorela
M
M
Halme
M
M
D015283:Citalopram / Q000009:adverse effects* / Q000627:therapeutic use; D004347:Drug Interactions; D006213:Hallucinogens / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
D015283:Citalopram; D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D017367:Selective Serotonin Reuptake Inhibitors